MDS Pharma Services enhances scientific capabilities with API 4000 LC/MS/MS system
2001
MDS Pharma Services Enhances Scientific Capabilities
publication
Author Information
Author(s): Jim Hulse
Primary Institution: MDS Pharma Services
Conclusion
MDS Pharma Services has acquired advanced instrumentation systems to improve bioanalytical research and drug development.
Supporting Evidence
- The API 4000 system offers a tenfold increase in sensitivity for many analytes compared to other systems.
- The BIACORE 3000 system provides advanced sensitivity and flexibility in bioanalytical research.
Takeaway
MDS Pharma Services bought new high-tech machines to help them analyze drugs better and faster.
Want to read the original?
Access the complete publication on the publisher's website